Skip to main content
. 2017 May 4;2017(5):CD006842. doi: 10.1002/14651858.CD006842.pub4
Methods RCT.
Parallel design.
Location: single centre in Australia.
Duration: at least 10 days.
Participants 23 children and adolescents with CF admitted to hospital for IV antibiotics for a respiratory exacerbation (as defined by Wood 2002). Needed previous experience at home with any PEP device. 1 from acapella group was discharged early on Day 6, so only 10 analysed in that group.
Age mean (SD) range: PEP 13.5 (3.3) 7 ‐ 18 years; acapella 10.4 (2.2) 7 ‐ 13 years.
Sex: PEP 9 females, 3 males; acapella 8 females, 2 males, the gender of the one participant from the acapella group who was discharged early was not identified in the paper.
FEV₁ % predicted mean (SD) range: PEP 74.67 (19.8)%, 56% ‐ 114%; acapella 58.9 (23)%, 29% ‐ 95%.
Exercise performance (m) mean (SD) range; PEP 798.3 (233.6), 390 ‐ 1100 m; acapella 576 (293.7), 290 ‐ 1200 m.
Interventions PEP mask (n = 12) versus acapella (n = 11).
2 supervised treatment sessions each day for a 10‐day period. Treatment was standardised to consist of 10 sets with the allocated device in a sitting position. Each set consisted of 10 breaths through the device followed by one or two huffs and cough. The pressure settings for the device were standardised for the study to provide between 15 and 20 cm H₂O of positive pressure.
All participants received concurrent IV antibiotics; any other treatment was in accordance with direction from a respiratory physician who was not aware of the treatment allocation of participants.
Outcomes Lung function, exercise performance (modified shuttle walk test), wet weight of sputum and satisfaction questionnaire.
Outcomes measured prior to randomisation and after 10 days.
Notes Sample size calculation undertaken (18 participants per treatment arm needed to detect a 10% change in FEV₁).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk 36 pieces of paper (18 PEP and 18 acapella) were put in double‐sealed envelopes and a research assistant (who was not involved with recruitment, assessment, or treatment) withdrew 1 envelope, determined group allocation, and then discarded the envelope.
Allocation concealment (selection bias) Low risk 36 pieces of paper (18 PEP mask and 18 acapella) were placed in double‐sealed envelopes and for each participant a research assistant (who was not involved with recruitment, assessment, or treatment) withdrew one envelope to determine group allocation
Blinding (performance bias and detection bias) All outcomes Low risk Outcome assessors were blinded for lung function and modified 10‐metre shuttle test.
Incomplete outcome data (attrition bias) All outcomes Low risk 22 out of 23 participants completed the study; 1 participant was discharged home on day 6 for home IV treatment and was not available to complete the 10 days of treatment.
Selective reporting (reporting bias) Low risk Limitations of the study were identified ‐ specifically smaller than planned sample size due to changes in clinical practice. This impacts the power of the study to detect an effect if one exists and may have contributed to lack of statistical differences between the intervention groups.
Other bias Unclear risk There appeared to be differences at baseline for age, FEV₁, and exercise performance. The PEP mask group was older, had a higher FEV₁, and could cover more distance in the 10‐metre shuttle test.
It was noted that parents were allowed to assist their child in completing the satisfaction questionnaire.

6MWD: six minute walk distance ACBT: active cycle of breathing ACT: airway clearance technique AD: autogenic drainage BMI: body mass index CF: cystic fibrosis CFRD: cystic fibrosis‐related diabetes CPT: chest physiotherapy FEF: forced expiratory flow FEV₁: forced expiratory volume at one second FVC: forced vital capacity HFCC: high frequency chest compression HFCWO: high force chest wall oscillation IPV: intrapulmonary percussive ventilator ITT: intention to treat IV: intravenous LCI: lung clearance index MEF: mid‐expiratory flow PD: postural drainage PD&C : postural drainage and clapping PD&P: postural drainage and percussion PEF: peak expiratory flow PEP: positive expiratory pressure PO₂: partial pressure of oxygen RCT: randomised controlled trial RFT: respiratory function test RV: residual volume SaO₂: pulse oximetry SD: standard deviation SpO₂: peripheral capillary oxygen saturation, an estimate of the amount of oxygen in the blood TLC: total lung capacity VC: vital capacity